Medical devices, healthcare technology and the business of care
510(k) clearance · K262125

Nenesupply Venus Handsfree Breast Pump (NBP001-HF)

Nenesupply Co., Ltd. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK262125

What did the FDA decide?

Nenesupply Co., Ltd. received a substantially equivalent (SESE) decision for the Nenesupply Venus Handsfree Breast Pump (NBP001-HF), a powered breast pump under 21 CFR 884.5160, product code HGX, in the Obstetrics/Gynecology specialty. FDA recorded the decision on 2026-10-29 for premarket notification K262125, received 06/24/2026 and handled as a Traditional 510(k) not reviewed by a third party. SESE means the device was cleared for marketing; it is not a PMA approval.

The record does not describe the device's components, materials, or performance testing, and the linked summary was not part of the public information, so the basis for the equivalence finding is unknown. The page also lists no combination product and no authorized predetermined change control plan. Clinical performance, indications wording, and any comparison to predicate devices remain unverified here and would need the original FDA documents.

For industry researchers, the entry is a dated clearance record for a single breast pump model from a New Taipei City applicant; it supports no inference about safety, efficacy, or labeling beyond the clearance itself.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Obstetrics/Gynecology
Decision date
Oct 29, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262125
Regulatory pathway
510(k) premarket notification
Product code
HGX
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pump, Breast, Powered.

Product code
HGX
FDA device class
2

FDA decision timeline

  1. K262125 received

    Application receipt date recorded by FDA.

  2. K262125 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HGX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Nenesupply Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
New Taipei City

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records